Jose has 10 years’ experience in antibody discovery and preclinical development in biotech and pharma. Jose is currently Director, Lead Adaptate Pre-Clinical at Takeda, where he is responsible for progressing programmes from discovery through clinical development. He was previously at F-star Therapeutics where he led immune cell engager programmes from inception to pre-IND, and beyond into Phase I, spanning multiple internal and external drug candidates, publications, and patents. He also held key platform, technology, and pharmacology development roles within F-star.
Before joining Adaptate (acquired by Takeda), Jose also held other scientific roles within AstraZeneca and Cambridge Antibody Technology.
Jose has a very keen interest in multispecific antibodies and multifunctional proteins, and the possibilities this type of drugs hold in addressing areas of highly unmet clinical needs.